.svg)
Science-backed
screening.
Our Evidence Framework
Four pillars that ensure every protocol we offer has genuine clinical value.
.svg)
Evidence-Based Protocols
Every screening protocol is grounded in peer-reviewed research. We don't offer tests without proven clinical value.
.svg)
Risk Stratification
Population-level data informs individual risk assessment. Your protocol is calibrated to your unique combination of risk factors.
.svg)
Outcome Tracking
We continuously monitor our detection rates, false positive rates, and patient outcomes to refine our protocols.
.svg)
Clinical Advisory Board
Our protocols are developed and reviewed by a board of subspecialist physicians from leading academic medical centers.
Our Process
A methodical, physician-led approach to preventive screening.
Early Detection of Coronary Artery Disease via Calcium Scoring
Coronary artery calcium (CAC) scoring reclassified 52% of intermediate-risk patients, enabling earlier intervention and reducing adverse cardiac events by 30% over 5 years.
Full-Body MRI for Asymptomatic Cancer Detection
Whole-body MRI screening detected clinically significant cancers in 2.3% of asymptomatic adults, with 67% of detected cancers at Stage I or II—when treatment is most effective.
Subspecialty vs. General Radiology Reads in Screening
Subspecialist radiologists demonstrated 23% higher sensitivity and 15% higher specificity compared to general radiologists in screening populations, with significantly fewer false positives.
Longitudinal Imaging for Cardiovascular Risk Monitoring
Serial imaging with annual CAC progression tracking identified high-risk trajectories 3.2 years earlier than traditional risk factor-based assessment alone.
Incidental Finding Management in Preventive Screening
Structured incidental finding protocols reduced unnecessary follow-up procedures by 41% while maintaining detection sensitivity, significantly reducing patient anxiety and healthcare costs.
Cost-Effectiveness of Risk-Stratified Preventive Imaging
Risk-stratified screening protocols showed a 2.8:1 cost-effectiveness ratio compared to uniform whole-body scanning, with higher disease detection rates and fewer radiation-related risks.
The Numbers Speak
Evidence from our screening programs and the broader preventive imaging literature.
of detected cancers found at Stage I-II
of patients reclassified by CAC scoring
reduction in unnecessary follow-ups
earlier high-risk identification
Physician-Led Prevention
Your scans are read by organ-specific subspecialists—not generalist radiologists. Neuroradiologists read brain imaging. Cardiothoracic specialists read cardiac CT. Body imaging experts handle abdominal MRI.
High-consequence findings receive second-read arbitration. And every client receives a 1:1 consultation with a physician who translates findings into a prioritized, actionable plan—not just a PDF of results.
.svg)
Evidence-Based Prevention Starts Here
Schedule a complimentary PreScan Consultation to discuss how our clinically restrained, longitudinal approach differs from mass-market screening.
.svg)
